Skip to main content
SpringerLink
Log in

Antineoplastics/cytarabine

Hepatic dysfunction and pneumonia: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Lei M, et al. Cytarabine, aclarubicin in combination with g-CSF (Cag) regimen represents an alternative re-induction option for non-remission acute myeloid leukemia. Acta Medica Mediterranea 35: 2561-2566, No. 5, 2019. Available from: URL: http://doi.org/10.19193/0393-6384_2019_5_402 - China

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics/cytarabine. Reactions Weekly 1774, 47 (2019). https://doi.org/10.1007/s40278-019-68494-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-68494-1

Search

Navigation